Single Dose Therapeutics

Biotechnology Research • • 1-10 Employees

Company overview

Headquarters	XX
Website	singledose.one
NAICS	541714
Employees	1-10

Key Contact at Single Dose Therapeutics

Davin Rautiola

Chief Executive Officer

Single Dose Therapeutics Email Formats

Single Dose Therapeutics uses 1 email format. The most common is {first name} (e.g., john@singledose.one), used 100% of the time.

Format	Example	Percentage
{first name}	john@singledose.one	100%

About Single Dose Therapeutics

Single Dose Therapeutics is dedicated to improving mental health care by developing short-regimen neuroplastogens that enhance psychological resilience. Our mission is to advance these innovative pharmacotherapies through rigorous research and clinical trials, ensuring they become accessible and effective treatment options for psychiatric conditions with unmet needs and those that currently require chronic treatment. We aim to provide interventions that foster durable mental well-being.

Single Dose Therapeutics revenue & valuation

Annual revenue	$85,555
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$273,776
Total funding	No funding

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Single Dose Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Single Dose Therapeutics has never raised funding before.

Frequently asked questions

Single Dose Therapeutics is located in XX.

Single Dose Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Single Dose Therapeutics

Davin Rautiola

Chief Executive Officer

4.8

40,000 users